摘要
背景:阿尔兹海默病(AD)是一个严重复杂的神经组织退化性疾病。目前,全球约有4千4百万人患有AD,并且由于人口变化这个数据将成倍增加。这种疾病可以通过药物途径和非药物途径治疗。不幸的是,至今无法治愈。尽管如此,治疗AD的药物仍然很昂贵、有不同的副作用并且只能延迟这种疾病的症状。因此,研究者建议使用各种非药物疗法。除了西方国家相对受欢迎的像身体活动、意识训练或者健康膳食等方法,中药治疗在开始欧洲可行 目的:这篇简短的回顾主要为了讨论中药的概念同时从治疗AD中探索他最普遍有效的形式。 方法:通过在世界数据库像科学网、Scopus、PubMed和Springer中搜索文献。 结果:我们讨论分析了五个随机对照临床实验。 结论:这篇简短回顾的作者列出了中药治疗AD的优势(像回顾从随机对照临床实验中得出提高AD患者意识衰退的研究方面的积极效果)和不足(像在欧洲传统中医药的较低的利益意识)的表格。
关键词: 阿尔兹海默病,中药,概念,发现,受益,局限。
Current Alzheimer Research
Title:Alzheimer's Disease and Chinese Medicine as a Useful Alternative Intervention Tool: A Mini-Review
Volume: 14 Issue: 6
关键词: 阿尔兹海默病,中药,概念,发现,受益,局限。
摘要: Background: Alzheimer´s disease (AD) is a serious and complex neurodegenerative disease. Currently, there are about 44 million people suffering from AD all over the world and this number is expected to rapidly grow due to demographic changes. The disease can be treated both pharmacologically and non-pharmacologically. Unfortunately, it cannot be cured yet. Nevertheless, the drugs for the treatment of AD are quite expensive, have different side effects and only delay symptoms of this disease. Therefore researchers suggest the use of various non-pharmacological therapies. Apart from relatively popular in western world such as physical activities, cognitive training or healthy diet, Chinese medicine starts to be practiced in Europe.
Objective: The purpose of this mini-review is to discuss the concept of Chinese medicine and explore its most common and effective forms in the treatment of AD. Methods: This was done by conducting a literature search in the world´s acknowledged databases such as Web of Science, Scopus, PubMed and Springer. Results: Five randomized controlled clinical trial studies were analyzed and their findings were discussed. Conclusion: The authors of this mini-review list the key benefits (e.g., positive results of the reviewed randomized clinical trials studies for the improvement of cognitive decline in AD) and limitations (e.g., low awareness of benefits of TCM in Europe) of Chinese medicine therapy for the treatment of AD.Export Options
About this article
Cite this article as:
Alzheimer's Disease and Chinese Medicine as a Useful Alternative Intervention Tool: A Mini-Review, Current Alzheimer Research 2017; 14 (6) . https://dx.doi.org/10.2174/1567205014666170117103656
DOI https://dx.doi.org/10.2174/1567205014666170117103656 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [ NeuroAIDS: A Neuroscience Problem with Global Impact ]
Current HIV Research Dipeptidyl Peptidase-4 Inhibition: Linking Chemical Properties to Clinical Safety
Current Medicinal Chemistry (Pro)renin Receptor as a New Drug Target
Current Pharmaceutical Design The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia
Current Pharmaceutical Design Protein Kinase CK2 in Human Diseases
Current Medicinal Chemistry One-Compound-Multi-Target: Combination Prospect of Natural Compounds with Thrombolytic Therapy in Acute Ischemic Stroke
Current Neuropharmacology Synthesis, Physico-Chemical Properties and DFT Calculations of New 2-(4- Arylpiperazine-1-yl)-1-(3-ethylbenzofuran-2-yl)ethanols As Potential Antihypertensive Agents
Current Organic Chemistry Serum S100B Represents a New Biomarker for Mood Disorders
Current Drug Targets Rational Basis for the Use of Bergamot Essential Oil in Complementary Medicine to Treat Chronic Pain
Mini-Reviews in Medicinal Chemistry The prediction of response to Galantamine treatment in Patients with mild to moderate Alzheimer’s Disease
Current Alzheimer Research Mass Spectrometric Analysis of F2-Isoprostanes: Markers and Mediators in Human Disease
Current Pharmaceutical Analysis Multiple Hormonal Dysregulation as Determinant of Low Physical Performance and Mobility in Older Persons
Current Pharmaceutical Design NAP (Davunetide) Provides Functional and Structural Neuroprotection
Current Pharmaceutical Design Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
Current Alzheimer Research Statins as Either Immunomodulators or Anti-Cancer Drugs: Functional Activities on Tumor Stromal Cells and Natural Killer Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Isoflurane Facilitates Synaptic NMDA Receptor Endocytosis in Mice Primary Neurons
Current Molecular Medicine Regional Cerebral Blood Flow and Cerebrovascular Reactivity in Alzheimer’s Disease and Vascular Dementia Assessed by Arterial Spinlabeling Magnetic Resonance Imaging
Current Neurovascular Research Suppression of Glial HO-1 Activitiy as a Potential Neurotherapeutic Intervention in AD
Current Alzheimer Research Prevalence, Incidence, Risk and Protective Factors of Amnestic Mild Cognitive Impairment in the Elderly in Shanghai
Current Alzheimer Research CD36 as a Therapeutic Target for Endothelial Dysfunction in Stroke
Current Pharmaceutical Design